Emyria Ltd (AU:EMD) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Emyria Ltd has secured $2.525 million in a placement supported by sophisticated investors to expand its mental health treatment programs, including those for PTSD and treatment-resistant depression, addressing significant unmet needs in Australia. The funds will help scale the company’s innovative treatment model, backed by a skilled clinical team and collaboration with major health payers, to improve patient access and wellbeing. Chairman Greg Hutchinson played a key role by committing $1 million of the investment.
For further insights into AU:EMD stock, check out TipRanks’ Stock Analysis page.